8:00 AM – 8:15 AM

WELCOME AND INTRODUCTIONS

8:15 AM – 9:30 AM

Mini Symposium on Follicular Lymphoma

• Molecular Genetics of FL
• Treatment of Newly Diagnosed Disease
• Treatment of Relapsed Disease and New Approvals

9:30 AM – 10:45 AM

Mini Symposium on CLL

• Frontline Treatment – Monotherapy, Double, or Triplet – What to Do?
• Biology of CLL at Progression: How Does That Inform Treatment
• Richter’s Transformation

10:45 AM – 11:00 AM

BREAK

11:00 AM – 12:00 PM

Chicago Hematopathology Multidisciplinary Tumor Board

• Hematopathologists and a Clinician Review Case Vignettes and Discuss the Interplay in Diagnosis

12:00 PM – 1:00 PM

Keynote Presentation: Pathogenesis and Clinical Course of Aggressive Lymphomas

1:00 PM

ADJOURN

TBD

Primer on Lymphoma

TBD

Toxicity of Immunotherapy in Frontline Therapy

• Side Effects of Immunotherapy

TBD

Practical Approach to Imaging in Patients with Lymphoma

TBD

Diving into the Diagnosis

• FISH and Other Laboratory Tests

TBD

ADJOURN

8:00 AM – 8:15 AM

WELCOME AND INTRODUCTIONS

8:15 AM – 9:30 AM

Mini Symposium on R/R DLBCL

• Cellular Therapy: Is the Efficacy of CAR T-cells Dependent Upon Lymphoma Subtype
• Immunotherapy Options for DLBCL Beyond CAR T-cells
• Non-Immunotherapy Options for R/R DLBCL

9:30 AM – 10:45 AM

Mini Symposium on T-Cell Lymphoma

• Systemic therapies for CTCL
• NewlyDiagnosed PTCL
• R/R PTCL

10:45 AM – 11:00AM

BREAK

11:00 AM – 12:00 PM

Mini Symposium on MCL

12:00 PM – 12:30 PM

Hodgkin Lymphoma: How Best to Incorporate Targeted Therapeutics into 1L Hodgkin Lymphoma

12:30 PM – 1:00 PM

Summary and “Best of IUCLS”

1:00 PM

ADJOURN